Results 261 to 270 of about 462,118 (388)

Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection. [PDF]

FASEB J
Galipeau Y, Castonguay N, McCluskie PS, Sonoda MT, Keeshan A, Collins E, Arnold C, Pelchat M, Burns K, Cooper C, Langlois MA.   +10 more
europepmc   +1 more source

Implementation of guidelines for intravenous iron therapy in heart failure patients

ESC Heart Failure, EarlyView.
Abstract Aims We aim to evaluate the implementation of the 2021 ESC Guidelines regarding screening and treatment of iron deficiency in patients with heart failure (HF) at Karolinska University Hospital. Methods and results Patients with left ventricular ejection fraction (LVEF) < 50% and New York Heart Association (NYHA) class II–IV who visited ...
Milou Gamage, Aristomenis Manouras, Camilla Hage, Gianluigi Savarese, Karin Ljung, Michael Melin   +5 more
wiley   +1 more source

Droplet microfluidic screening to engineer angiotensin-converting enzyme 2 (ACE2) catalytic activity. [PDF]

J Biol Eng
Okal EF, Romero PA, Heinzelman P.
europepmc   +1 more source

Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failure

ESC Heart Failure, EarlyView.
Abstract Aims Most proteomic analyses in patients with heart failure (HF) focus on the stable ambulatory setting; pathways that drive acute decompensated heart failure (ADHF) are largely uncharacterized. We aimed to examine the associations of cardiometabolic proteins with HF rehospitalization, mortality and diuretic response in patients with ADHF ...
Kenneth T. Hubbell, Veena S. Rao, Rebecca Scherzer, Michael G. Shlipak, Juan B. Ivery‐Miranda, Nisha Bansal, Zachary L. Cox, Jeffrey M. Testani, Michelle M. Estrella   +8 more
wiley   +1 more source

COVID-19 Pandemic Waves and 2024-2025 Winter Season in Relation to Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and Amantadine. [PDF]

Healthcare (Basel)
Puigdellívol-Sánchez A, Juanes-González M, Calderón-Valdiviezo AI, Losa-Puig H, González-Salvador M, León-Pérez M, Pueyo-Antón L, Franco-Romero M, Lozano-Paz C, Cortés-Borra A, Valls-Foix R.   +10 more
europepmc   +1 more source

Disparate Effects of Angiotensin Converting Enzyme Inhibitor and Calcium Blocker Treatment on the Preservation of Renal Structure and Function Following Subtotal Nephrectomy or Streptozotocin-Induced Diabetes in the Rat

, 1987
B. Jackson, R. Cubela, L. Debrevi, M. Whitty, C. I. Johnston   +4 more
openalex   +1 more source

Constrasts and similarities of acute hemodynamic responses to specific antagonism of angiotensin II ([Sar1, Thr8] A II) and to inhibition of converting enzyme (captopril). [PDF]

, 1980
F. M. Fouad, Joanne Ceimo, Robert C. Tarazi, Elena Bravo   +3 more
openalex   +1 more source

Interconnected pathways and emerging therapies in chronic kidney disease and heart failure: A comprehensive review

ESC Heart Failure, EarlyView.
Abstract Chronic kidney disease (CKD) and chronic heart failure (HF) frequently coexist and, when comorbid, are associated with poorer outcomes. These two diseases have common risk factors, such as diabetes, obesity and hypertension, and common pathophysiological connected mechanisms, including inflammation, endothelial dysfunction, neurohormonal ...
Johann Bauersachs, Eri Toda Kato, Janani Rangaswami   +2 more
wiley   +1 more source

Rabbit and Human Angiotensin-Converting Enzyme-2: Structure and Electric Properties. [PDF]

Int J Mol Sci
Hristova SH, Popov TT, Zhivkov AM.
europepmc   +1 more source

Improved micromethod for assay of serum angiotensin converting enzyme. [PDF]

, 1982
Hugo Neels, Simon Scharpé, M E van Sande, Robert Verkerk, K J Van Acker   +4 more
openalex   +1 more source